Biocon Chairperson lashes out at govt capping Covid-19 vaccine price at Rs 250 at private hospitals

Published On 2021-03-01 06:37 GMT   |   Update On 2021-03-01 08:15 GMT

New Delhi: Biocon Chairperson Kiran Mazumdar Shaw on Sunday hit out at the government capping Covid-19 vaccine price at Rs 250 at private hospitals, saying vaccine companies "feel betrayed" as it is too low to sustain.Reacting to a report that the health ministry has fixed Rs 250 per shot at private hospitals and health centres, she tweeted, "We are (sic) crushing instead of incentivising...

Login or Register to read the full article

New Delhi: Biocon Chairperson Kiran Mazumdar Shaw on Sunday hit out at the government capping Covid-19 vaccine price at Rs 250 at private hospitals, saying vaccine companies "feel betrayed" as it is too low to sustain.

Reacting to a report that the health ministry has fixed Rs 250 per shot at private hospitals and health centres, she tweeted, "We are (sic) crushing instead of incentivising vaccine industry."
She further said, "Covid Vaccine Jab Capped At Rs 250 At Private Hospitals: Government - understand vaccine cos (sic) feel betrayed as price is too low to sustain."
Mazumdar-Shaw asked, "If WHO has agreed to USD 3 per dose, why beat them down to USD 2?"
The government's capping of the vaccine price at private hospitals comes at a time when India is preparing to vaccinate people aged above 60 years and those over 45 with co-morbidities from March 1.
The Covid-19 vaccine will be given free of cost at government hospitals, while people will need to pay for it at private facilities.
It is understood that the Rs 250 ceiling per dose includes Rs 150 per dose of vaccine plus Rs 100 service charge.


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News